Oncology-related issues of angiotensin-receptor blockers

Orvosi hetilap
András Telekes, István Kiss

Abstract

Recently controversial data emerged regarding the cancer inducing activity of angiotensin-receptor blockers. There may be several reasons which may explain the controversial data published in the scientific literature including wrong trial design or misinterpretation of data. Considering the large number of patients receiving treatment for hypertension, it is essential to have a clear view of the cancer-related safety of these drugs. This paper tries to give an overview on this issue based on data available in the literature. According to our present knowledge, angiotensin-receptor blockers exert more likely anticancer activity rather than carcinogenesis inducing effect. In fact, some oncologic trials point to this direction, because angiotensin-receptor blockers are suggested as co-treatment to chemotherapy in cases of pancreatic, oesophageal and gastric cancers.

References

Apr 21, 1982·The American Journal of Cardiology·J O Davis, R H Freeman
Sep 15, 1998·Kidney International. Supplement·O ChungT Unger
Mar 17, 1999·Journal of Human Hypertension·O ChungT Unger
Jun 1, 2002·Circulation Research·Jean-Sébastien SilvestreBernard I Lévy
Apr 5, 2003·The International Journal of Biochemistry & Cell Biology·Yusuke SuzukiJesus Egido
Jul 4, 2003·The Journal of Clinical Investigation·Kimiyasu EgamiTsutomu Imaizumi
Sep 19, 2003·Lancet·Marc A PfefferUNKNOWN CHARM Investigators and Committees
Jun 5, 2004·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·D MennerichA Sommer
Apr 9, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Takayasu SuganumaFumitaka Kikkawa
Aug 3, 2005·Trends in Endocrinology and Metabolism : TEM·Frédérique Deshayes, Clara Nahmias
Mar 1, 2006·Expert Opinion on Biological Therapy·Kazuhiko InoFumitaka Kikkawa
Jul 18, 2006·Mini Reviews in Medicinal Chemistry·Hiroji UemuraYoshinobu Kubota
Sep 16, 2006·Arteriosclerosis, Thrombosis, and Vascular Biology·Hideto SanoNobuyuki Takakura
Jan 19, 2007·American Journal of Physiology. Renal Physiology·Nicole SchuppHelga Stopper
Sep 20, 2007·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·K OhwadaI Ohno
Mar 4, 2008·Endocrine-related Cancer·M A Redondo-MüllerG P Vinson
May 6, 2008·Lancet·Carlene M M LawesUNKNOWN International Society of Hypertension
Jul 18, 2008·Carcinogenesis·Eleanor I AgerChristopher Christophi
Oct 23, 2010·European Heart Journal·Massimo VolpeLuis M Ruilope
Oct 23, 2010·Nature Reviews. Cancer·Amee J GeorgeRoss D Hannan
Jan 11, 2011·Journal of Korean Medical Science·Ho Jun ChinUNKNOWN Members of The PREMIER Group
Jan 25, 2011·The American Journal of Cardiology·Chin-Chou HuangHsin-Bang Leu
Feb 15, 2011·Current Opinion in Pharmacology·Babbette LaMarcaJoey Granger
Apr 13, 2011·Circulation·Björn PasternakAnders Hviid
Jun 22, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Chia-Hsuin ChangMei-Shu Lai
Sep 21, 2011·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·G Opelz, B Döhler
Nov 8, 2011·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Jacqueline L OlinDonald S Nuzum
Aug 9, 2012·Annals of Surgical Oncology·Kazuyuki YugeMototsugu Oya

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Related Papers

The Australian and New Zealand Journal of Surgery
M H Tattersall
Clinical Oncology : a Journal of the Royal College of Radiologists
P Clark
© 2022 Meta ULC. All rights reserved